MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-23-2026
West Pharmaceutical Services Operating Cash Flow 2011-2026 | WST
Annual Operating Cash Flow West Pharmaceutical Services
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 755 M | 653 M | 776 M | 724 M | 584 M | 472 M | 367 M | 289 M | 263 M | 219 M | 212 M | 183 M | 220 M | 187 M | 131 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 776 M | 131 M | 403 M |
Quarterly Operating Cash Flow West Pharmaceutical Services
| 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 89.9 M | - | - | - | 129 M | - | - | - | 118 M | - | - | - | 138 M | - | 493 M | - | 151 M | - | 423 M | - | 88.7 M | - | 324 M | 205 M | 57.1 M | - | 261 M | 153 M | 47.6 M | - | 215 M | 127 M | 45 M | - | 182 M | 106 M | 20.7 M | - | 148 M | 79.2 M | 3 M | - | 144 M | 75.6 M | -1.9 M | - | 137 M | 73 M | 8.8 M | - | 152 M | 98.4 M | 18.9 M | - | 118 M | 66 M | 13.8 M | - | 88.9 M | 49.2 M | 9.5 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 493 M | -1.9 M | 123 M |
Operating Cash Flow of other stocks in the Medical instruments industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
20 K | - | - | $ 810 M |  USA |
 |
iRhythm Technologies
IRTC
|
80.9 M | $ 126.93 | 3.74 % | $ 4.06 B | USA |
 |
Alcon
ALC
|
1.34 B | $ 76.13 | 0.46 % | $ 40.4 B |  Schweiz |
 |
Ekso Bionics Holdings
EKSO
|
-11.8 M | $ 10.93 | -0.55 % | $ 26.5 M | USA |
 |
The Cooper Companies
COO
|
796 M | $ 64.3 | -0.19 % | $ 12.8 B | USA |
 |
Repro Med Systems
KRMD
|
462 K | $ 4.03 | 1.77 % | $ 186 M | USA |
 |
Microbot Medical
MBOT
|
-13 M | $ 2.17 | -1.36 % | $ 99.4 M |  Israel |
 |
Milestone Scientific
MLSS
|
-2.92 M | $ 0.32 | 1.15 % | $ 26.3 M | USA |
 |
Haemonetics Corporation
HAE
|
182 M | $ 60.81 | 1.38 % | $ 3.06 B | USA |
 |
electroCore
ECOR
|
-8.19 M | $ 6.07 | -1.7 % | $ 51.5 K | USA |
 |
ICU Medical
ICUI
|
180 M | $ 122.32 | -2.0 % | $ 3.01 B | USA |
 |
Envista Holdings Corporation
NVST
|
276 M | $ 26.79 | - | $ 4.5 B | USA |
 |
Isoray
ISR
|
-82.5 M | - | 0.03 % | $ 108 M | USA |
 |
Intuitive Surgical
ISRG
|
3.03 B | $ 471.29 | -2.27 % | $ 168 B | USA |
 |
Glaukos Corporation
GKOS
|
-57.8 M | $ 121.88 | 0.18 % | $ 5.9 B | USA |
 |
STERIS plc
STE
|
1.15 B | $ 221.92 | 0.08 % | $ 21.9 B | USA |
 |
Masimo Corporation
MASI
|
196 M | $ 178.6 | -0.02 % | $ 9.52 B | USA |
 |
InfuSystem Holdings
INFU
|
17.5 M | $ 10.6 | 2.71 % | $ 219 M | USA |
 |
Merit Medical Systems
MMSI
|
297 M | $ 67.27 | -1.91 % | $ 3.98 B | USA |
 |
Utah Medical Products
UTMD
|
14.7 M | $ 67.07 | -0.15 % | $ 217 M | USA |
 |
Pulse Biosciences
PLSE
|
-54.1 M | $ 22.39 | -2.74 % | $ 1.51 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
235 M | $ 11.9 | -0.13 % | $ 2.37 B | USA |
 |
Retractable Technologies
RVP
|
-7.06 M | $ 0.63 | -1.72 % | $ 18.9 M | USA |
 |
Pro-Dex
PDEX
|
-1.68 M | $ 51.94 | -0.32 % | $ 171 M | USA |
 |
LeMaitre Vascular
LMAT
|
81.3 M | $ 115.31 | 1.64 % | $ 2.61 B | USA |
 |
Predictive Oncology
POAI
|
-12.4 M | - | - | $ 31.1 M | USA |
 |
STAAR Surgical Company
STAA
|
-34.2 M | $ 26.2 | 2.06 % | $ 1.3 B | USA |
 |
BioLife Solutions
BLFS
|
8.43 M | $ 21.31 | -0.33 % | $ 982 M | USA |
 |
Stereotaxis
STXS
|
-13.7 M | $ 1.94 | 0.26 % | $ 176 M | USA |
 |
Baxter International
BAX
|
845 M | $ 18.46 | 1.68 % | $ 9.47 B | USA |
 |
ResMed
RMD
|
351 M | $ 222.96 | 1.47 % | $ 32.6 B | USA |
 |
AtriCure
ATRC
|
57.3 M | $ 29.06 | -0.75 % | $ 1.39 B | USA |
 |
Harvard Bioscience
HBIO
|
6.73 M | $ 6.56 | -4.37 % | $ 291 M | USA |
 |
NeuroMetrix
NURO
|
-7.13 M | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
-10.1 M | $ 11.01 | -0.81 % | $ 450 M | USA |
 |
Becton, Dickinson and Company
BDX
|
3.33 B | $ 150.72 | -0.92 % | $ 43.4 B | USA |
 |
Nephros
NEPH
|
827 K | $ 2.99 | 4.3 % | $ 31.1 M | USA |
 |
OraSure Technologies
OSUR
|
-49 M | $ 2.97 | -1.17 % | $ 218 M | USA |
 |
Repligen Corporation
RGEN
|
114 M | $ 118.39 | 0.67 % | $ 6.6 M | USA |